Zilganersen
- Generic Name
- Zilganersen
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 2305355-56-8
- Unique Ingredient Identifier
- AXQ9493NT2
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD)
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Ionis Pharmaceuticals, Inc.
- Target Recruit Count
- 73
- Registration Number
- NCT04849741
- Locations
- 🇬🇧
University College London Hospitals NHS Foundation Trust, London, United Kingdom
🇺🇸Children's Hospital of Atlanta, Atlanta, Georgia, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath